We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

1 hedge funds and large institutions have $24K invested in GW Pharmaceuticals Plc American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NEWAS
N.E.W. Advisory Services
Wisconsin
+$24K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NEWAS
1
N.E.W. Advisory Services
Wisconsin
$24K +$24K +109 New

GWPH Hedge Fund Activity: Q1 2022 in Review

1 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q1 2022, worth a combined $24K.

Buyers outnumbered sellers: 1 fund opened new GWPH positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was N.E.W. Advisory Services, opening a new position worth an estimated $24K.

  • 1 institutional investor held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q1 2022, up from 0 in Q4 2021.
  • Funds reported $24K of GW Pharmaceuticals Plc American Depositary Shares stock for Q1 2022.
  • 1 fund opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q1 2022 and 0 closed out, a net change of +1 holder.
  • The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q1 2022 was N.E.W. Advisory Services, an estimated $24K added.

Based on aggregated 13F filings for Q1 2022.